Laurel Crosby

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Laurel Crosby, PhD, is Engineering Research Associate with the Stanford Genome Technology Center.[1]

Notable studies[edit | edit source]

  • 2021, Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole[2] (Full text)
correction

See also[edit | edit source]

References[edit | edit source]

  1. ↑ "Meet Laurel Crosby, PhD, member of the SGTC Team". Open Medicine Foundation. August 8, 2018. Retrieved January 20, 2019.
  2. ↑ Crosby, L. D.; Kalanidhi, S.; Bonilla, A.; Subramanian, A.; Ballon, J.S.; Bonilla, H. (February 3, 2021). "Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole". Journal of Translational Medicine. 19 (1): 50. doi:10.1186/s12967-021-02721-9. ISSN 1479-5876. PMC 7860172. PMID 33536023.
Retrieved from "https://me-pedia.org/w/index.php?title=Laurel_Crosby&oldid=225929"